IIJI News Alert Internet Initiative Japan (IIJI) 9.38 11/13/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Internet Initiative Japan (IIJI) 9.38 $IIJI

Internet Initiative Japan Down 13.4% Since SmarTrend Downtrend Call (IIJI)
Comtex SmarTrend(R) - Wed Nov 12, 10:03AM CST
SmarTrend identified a Downtrend for Internet Initiative Japan (NASDAQ:IIJI) on June 25th, 2014 at $10.89. In approximately 5 months, Internet Initiative Japan has returned 13.41% as of today's recent price of $9.43.
IIJI: 9.38 (+0.22)

IIJ Corrects Number of Contracts for Connectivity Services as Announced in Its Financial Results and Presentation Material for the First Six Months of the Fiscal Year Ending March 31, 2015
GlobeNewswire - Mon Nov 10, 5:39PM CST
Internet Initiative Japan Inc. ("IIJ" (Nasdaq:IIJI) (TSE1:3774) has partially corrected its Number of Contracts for Connectivity Services announced on November 7, 2014 in its financial results and presentation material for the first six months of the fiscal year ending March 31, 2015. The corrected points are underlined and italicized.
IIJI: 9.38 (+0.22)

Internet Initiative Japan EPS of ¥10.36
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 3:03AM CST

IIJI: 9.38 (+0.22)

IIJ Announces First Six Months Financial Results for the Fiscal Year Ending March 31, 2015
GlobeNewswire - Thu Nov 06, 9:07PM CST
Internet Initiative Japan Inc. ("IIJ" (Nasdaq:IIJI) (TSE:3774) today announced its consolidated financial results for the first six months of the fiscal year ending March 31, 2015 (from April 1, 2014 to September 30, 2014, "1H FY2014", "1H14" .
IIJI: 9.38 (+0.22)

IIJ and Biznet to Run a Joint Cloud Venture in Indonesia
GlobeNewswire - Wed Nov 05, 8:10PM CST
Internet Initiative Japan Inc. (IIJ) (Nasdaq:IIJI) (TSE:3774), one of Japan's leading Internet access and comprehensive network solutions providers, today announced that it has reached an agreement with Biznet Networks (Biznet) to establish a joint venture in Indonesia. IIJ aims to enhance its existing cloud services in the ASEAN region. Biznet Networks (Indonesian name: PT. Supra Primatama Nusantara), headquartered in Jakarta, is a major communications services company in Indonesia.
IIJI: 9.38 (+0.22)

Internet Initiative Japan Shares Down 22.9% Since SmarTrend's Sell Call (IIJI)
Comtex SmarTrend(R) - Wed Nov 05, 9:38AM CST
SmarTrend identified a Downtrend for Internet Initiative Japan (NASDAQ:IIJI) on June 25th, 2014 at $10.89. In approximately 4 months, Internet Initiative Japan has returned 22.87% as of today's recent price of $8.40.
IIJI: 9.38 (+0.22)

Baidu (BIDU) Beats Q3 Earnings Backed by Higher Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 8:30AM CDT
China's largest search engine, Baidu, Inc. (BIDU) reported adjusted third-quarter 2014 earnings of $1.79 per share, exceeding the Zacks Consensus Estimate of $1.62 due to higher volumes.
INUV: 1.45 (-0.06), BIDU: 244.09 (-5.73), NPTN: 2.95 (-0.06), IIJI: 9.38 (+0.22)

Facebook Posts Solid Q3 Earnings, Ad Revenues a Key Driver - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 10:33AM CDT
Facebook Inc. (FB) reported impressive third-quarter 2014 results reflecting its growing dominance in the mobile advertising market.
INUV: 1.45 (-0.06), FB: 74.25 (-0.47), LPSN: 13.89 (-0.47), IIJI: 9.38 (+0.22)

Internet Initiative Japan Has Returned 22.4% Since SmarTrend Recommendation (IIJI)
Comtex SmarTrend(R) - Tue Oct 14, 11:03AM CDT
SmarTrend identified a Downtrend for Internet Initiative Japan (NASDAQ:IIJI) on June 25th, 2014 at $10.89. In approximately 4 months, Internet Initiative Japan has returned 22.41% as of today's recent price of $8.45.
IIJI: 9.38 (+0.22)

M3AAWG Releases First Bot Metrics Directly From Network Operators, Offers Insiders' View on the Pervasiveness of Malware
Marketwired - Tue Oct 14, 10:00AM CDT
Each month, over 1% percent of unique consumer network subscribers are identified as having some type of malware on their systems with service providers notifying 94 to 99 percent of those users about the problem, according to a report released today from the Messaging, Malware and Mobile Anti-Abuse Working Group. The new M3AAWG Bot Metrics and its ongoing reporting program is the first industry assessment that is based on data collected directly from service providers indicating what percentage of consumers are infected with malicious code.
T: 35.61 (+0.21), ORA: 27.11 (+0.32), CMCSA: 54.30 (+0.70), IIJI: 9.38 (+0.22), CTL: 40.92 (+0.42)

Downtrend Call Working As Internet Initiative Japan Stock Falls 17.3% (IIJI)
Comtex SmarTrend(R) - Tue Oct 07, 9:46AM CDT
SmarTrend identified a Downtrend for Internet Initiative Japan (NASDAQ:IIJI) on June 25th, 2014 at $10.89. In approximately 3 months, Internet Initiative Japan has returned 17.28% as of today's recent price of $9.01.
IIJI: 9.38 (+0.22)

IIJ Announces First Three Months Financial Results for the Fiscal Year Ending March 31, 2015
GlobeNewswire - Thu Aug 07, 10:08PM CDT
Internet Initiative Japan Inc. ("IIJ" (Nasdaq:IIJI) (TSE:3774) today announced its consolidated financial results for the first three months of the fiscal year ending March 31, 2015 (1Q14, from April 1, 2014 to June 30, 2014).
IIJI: 9.38 (+0.22)

IIJ Announces the Filing of Annual Report on Form 20-F With the U.S. Securities and Exchange Commission
GlobeNewswire - Wed Jul 16, 5:12AM CDT
Internet Initiative Japan Inc. ("IIJ" (Nasdaq:IIJI) (TSE1:3774) announces that IIJ has filed its annual report on Form 20-F for the fiscal year ended March 31, 2014 (the "Annual Report" with the U.S. Securities and Exchange Commission. The Annual Report includes IIJ's audited consolidated financial statements prepared under U.S. GAAP as of and for the fiscal year ended March 31, 2014. The Annual Report is available on IIJ's following website:
IIJI: 9.38 (+0.22)

Notice Regarding the Terms and Conditions Concerning the Issuance of Stock-Compensation-Type Stock Options (Stock Acquisition Rights)
GlobeNewswire - Thu Jul 10, 4:04AM CDT
Internet Initiative Japan Inc. ("IIJ", the "Company" (Nasdaq:IIJI) (TSE1:3774) hereby announces that it has determined the remaining terms and conditions concerning the issuance of stock-compensation-type stock options ("Stock Acquisition Rights" , resolved by the IIJ's Board of Directors on June 25, 2014, to be allotted to Directors (excluding Part-time and Outside Directors) and Executive Officers of IIJ, as follows.
IIJI: 9.38 (+0.22)

Notice Regarding Issuance of Stock-Compensation-Type Stock Options (Stock Acquisition Rights)
GlobeNewswire - Wed Jun 25, 1:14AM CDT
Internet Initiative Japan Inc. ("IIJ," the "Company" (Nasdaq:IIJI) (TSE1:3774) announced that IIJ's Board of Directors today resolved that stock-compensation-type stock options (Stock Acquisition Rights) be issued to Directors (excluding Part-time and Outside Directors) and Executive Officers of IIJ, in accordance with the provisions of Articles 236 Paragraph 1, Article 238 Paragraph 1 and 2 and Article 240 Paragraph 1 of the Company Law, as follows.
IIJI: 9.38 (+0.22)

Internet Initiative Japan Up 12.6% Since SmarTrend Uptrend Call (IIJI)
Comtex SmarTrend(R) - Tue Jun 17, 9:14AM CDT
SmarTrend identified an Uptrend for Internet Initiative Japan (NASDAQ:IIJI) on March 12th, 2014 at $10.97. In approximately 3 months, Internet Initiative Japan has returned 12.63% as of today's recent price of $12.35.
IIJI: 9.38 (+0.22)

Shares of IIJI Down 37.5% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Mon Mar 10, 9:45AM CDT
SmarTrend identified a Downtrend for Internet Initiative Japan (NASDAQ:IIJI) on July 29th, 2013 at $16.47. In approximately 7 months, Internet Initiative Japan has returned 37.46% as of today's recent price of $10.30.
IIJI: 9.38 (+0.22)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 295

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 143

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 132

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 143

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 214

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 160

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 185

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 70

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 270

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 69

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading

Top 5 Most Recently Viewed Articles

WTW Welcomes Dale Porfilio as Director for Business Development

Updated Category News Views 138

WTW Appoints New Leader for Business Development In a significant move to enhance its operations, WTW (NASDAQ: WTW) has announced the appointment of Dale Porfilio as Senior Director and Head of Personal and Commercial Lines Business Development within its Insurance Consulting & Technology (ICT) segment. A Seasoned Professional Joins WTW Porfilio brings a wealth of...

Continue Reading
Jorgen Vig Knudstorp's Bold Stock Purchase at Starbucks

Updated Category News Views 74

Jorgen Vig Knudstorp Invests in Starbucks, Showing Strong Confidence Recently, Jorgen Vig Knudstorp, a director at Starbucks Corp (NASDAQ:SBUX), made a significant move by buying shares of the company. This act signals a firm vote of confidence in the future of the beloved coffee chain. When insiders make such investments, it often grabs the attention of other investors...

Continue Reading
Understanding Inventiva's Latest Half-Year Report and Future Plans

Updated Category News Views 65

Inventiva Files its 2024 Half-Year Report Inventiva, a prominent clinical-stage biopharmaceutical company, is making significant strides in the healthcare sector. Focused on developing oral therapies for metabolic dysfunction-associated steatohepatitis, commonly known as MASH/NASH, the company recently announced its filing of the 2024 Half-Year Report for the period...

Continue Reading
Analyzing Organon's Upcoming Earnings Announcement and Insights

Updated Category News Views 177

Anticipation Surrounding Organon's Earnings Report Organon (OGN) is on the verge of revealing its quarterly earnings report, a moment eagerly awaited by investors. As preparations finalize for this significant announcement, understanding the forecasted outcomes can guide investor decisions moving forward. Expected Earnings Figures Forecast estimates suggest that Organon...

Continue Reading
Miami Real Estate Trends: A Surge in Older Condo Sales

Updated Category News Views 180

Understanding the Miami-Dade Real Estate Market Miami-Dade County's real estate landscape is shifting, with older condominiums experiencing quicker sales than their newer counterparts. This trend indicates a solid demand for older condos, highlighting their appeal in a market where affordable housing options continue to thrive. Statistical data reveal that older...

Continue Reading